Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi

Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi

Item

http://www.wikidata.org/entity/Q28387497

Q28387497

about

Prevalence and clinical features of HIV and malaria co-infection in hospitalized adults in Beira, Mozambique Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria?Assessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles Prevalence of malaria and anaemia among HIV infected pregnant women receiving co-trimoxazole prophylaxis in Tanzania: a cross sectional study in Kinondoni Municipality.The impact of home-based HIV counseling and testing on care-seeking and incidence of common infectious disease syndromes in rural western Kenya.Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women A Public Health Paradox: The Women Most Vulnerable to Malaria Are the Least Protected Molecular markers in plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy.Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda.Trimester-Specific Population Pharmacokinetics and Other Correlates of Variability in Sulphadoxine-Pyrimethamine Disposition Among Ugandan Pregnant Women.The effect of HIV infection on the risk, frequency, and intensity of Plasmodium falciparum parasitemia in primigravid and multigravid women in Malawi.Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa.Impact of cotrimoxazole and insecticide-treated nets for malaria prevention on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review.Quantification of the burden and consequences of pregnancy-associated malaria in the Democratic Republic of the Congo.The effect of cotrimoxazole prophylactic treatment on malaria, birth outcomes, and postpartum CD4 count in HIV-infected women Implementation of co-trimoxazole preventive therapy policy for malaria in HIV-infected pregnant women in the public health facilities in Tanzania.Changing the policy for intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy in Malawi.Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy.Emerging drugs for malaria.A systematic review of the impact of malaria prevention in pregnancy on low birth weight and maternal anemia.Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial.Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women.Dosage of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in a Cohort of Zambian Pregnant Women in a Low Malaria Prevalence Region.Effect of cotrimoxazole prophylaxis on malaria occurrence among HIV-infected adults in West Africa: the MALHIV Study.HIV infection in pregnancy: maternal and perinatal outcomes in a tertiary care hospital in Calabar, Nigeria.Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial.Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa.A brief review on features of falciparum malaria during pregnancy.Use of trimethoprim-sulfamethoxazole during pregnancy and risk of spontaneous abortion: a nested case control study.

P2860

Q21034056-0EBB3D14-F009-488C-B5D9-E36391C1F46A Q21133667-BBBAD8A6-AEDD-4B5C-8E4D-B3FD0D3ED7FD Q24236135-0ABB6EBC-D8F2-4944-A17B-4F286F42CA54 Q28076750-1F984041-8E55-484F-9464-D0D9D1273571 Q28084544-50B6CF68-6B58-4992-9720-32362C275732 Q28125916-349E5489-2322-4B4E-ACCF-87D5F4041A49 Q31159619-D2D60345-84A2-48AC-8DC3-538CD4EBFD8E Q33938430-478CA4FB-072B-4979-BE0A-F48DF3C914EF Q34974794-0CA9236A-82A6-4D67-9126-8BE0C6D48F37 Q36006670-6432C81B-C147-423A-8F22-71112DBDAF58 Q36051104-D2B7F6D1-FDD6-4241-B0AD-2E5D2F4F4AB6 Q36094714-EE37640B-7DD1-4900-AAE4-F7C5724FA3FB Q36327790-E9EBF966-BCAD-4C7F-946E-70017BDB4272 Q36450099-4589013E-AF65-4CC8-8E33-D5840FA19F93 Q36461809-80D67F47-A643-42E4-8D49-B6D53535B4C5 Q36504556-AC592CAC-6F3A-4DB8-B4D9-DB970724F905 Q36759511-C5209C99-3EF7-4136-8B77-782BF323682F Q36792779-2A957591-0BDE-44EF-A683-18A3574633E8 Q37398249-106170BD-6EB8-4A38-A28A-6B51DCB31875 Q37515760-34F368A2-EEDD-4572-9E84-5E67DCD298DE Q37655364-C5FEC0EA-A727-456D-A373-B1C6F2DE591C Q37863203-D0BA7EE6-5CD7-4744-AD45-6024FE91C021 Q38027179-3B1B0561-3CF6-4097-A977-DFFC7BFD1529 Q38089388-78BD0C80-8008-4C7F-8C5A-9B7D7309AB1C Q38843857-82136232-9B6A-455F-96D9-AAC41A6A7FD9 Q38850820-8E57C904-F355-4515-8B1C-75E050E69B8D Q39229580-603A817D-11A9-47DF-B6A1-F20EA56B45A8 Q40144262-F4AC5039-7682-4CD6-94CA-10250FCB3D6A Q41009385-16FD0E53-4363-4345-B4CA-3EE8EF139955 Q42249162-FC6BC787-9A96-4F84-BD33-50DCE195BA71 Q46302284-05B0E375-1B2A-4956-BD7F-DE4562189229 Q49874138-521E1AE1-8670-485E-9230-C1BCEFA61B89 Q50103216-29B642D7-889A-432F-8195-1783520433DE

P2860

Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi

Item

http://www.wikidata.org/entity/Q28387497

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu